ArticleAmerican journal of hematology2021

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.

Enrico Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.